Parasitology

🪱Parasitology Unit 8 – Immune Responses to Parasitic Infections

Parasitic infections pose significant health challenges worldwide. From single-celled protozoa to complex helminths, these organisms have evolved intricate strategies to invade hosts and evade immune responses. Understanding how our bodies recognize and fight these invaders is crucial for developing effective treatments. The immune system employs a two-pronged approach against parasites: innate and adaptive immunity. Innate responses provide rapid, non-specific defense, while adaptive immunity offers targeted, long-lasting protection. This complex interplay between parasites and host immunity shapes the course of infection and disease outcomes.

Key Parasites and Their Characteristics

  • Protozoan parasites (Plasmodium, Toxoplasma, Trypanosoma) are single-celled eukaryotic organisms that can cause severe diseases in humans
    • Plasmodium species cause malaria, a potentially life-threatening disease transmitted by mosquitoes
    • Toxoplasma gondii is an intracellular parasite that can cause toxoplasmosis, particularly dangerous for pregnant women and immunocompromised individuals
  • Helminthic parasites (roundworms, tapeworms, flukes) are multicellular organisms that often have complex life cycles involving multiple hosts
    • Schistosoma species are blood flukes that cause schistosomiasis, a chronic disease affecting millions worldwide
    • Taenia solium is a tapeworm that can cause cysticercosis, a condition where larvae invade various tissues, including the brain
  • Many parasites have specialized structures (hooks, suckers, adhesion proteins) that enable them to attach to and invade host tissues
  • Parasites often exhibit antigenic variation, a process by which they alter their surface proteins to evade host immune recognition
  • Some parasites (Trypanosoma cruzi) can enter and survive within host cells, providing protection from immune responses

Immune System Basics

  • The immune system consists of two main branches: innate immunity and adaptive immunity
    • Innate immunity provides rapid, non-specific defense against pathogens
    • Adaptive immunity is slower to develop but provides specific, long-lasting protection
  • Key cells of the innate immune system include macrophages, dendritic cells, neutrophils, and natural killer cells
    • Macrophages are phagocytic cells that engulf and destroy pathogens and infected cells
    • Dendritic cells are antigen-presenting cells that link innate and adaptive immunity by activating T cells
  • Lymphocytes (T cells and B cells) are the main components of the adaptive immune system
    • T cells are involved in cell-mediated immunity and help coordinate the overall immune response
    • B cells produce antibodies, which are key mediators of humoral immunity
  • Cytokines are signaling molecules that regulate and coordinate immune responses
    • Pro-inflammatory cytokines (IL-1, IL-6, TNF-α) promote inflammation and activate immune cells
    • Anti-inflammatory cytokines (IL-10, TGF-β) help control and resolve immune responses

Parasite Recognition by the Immune System

  • Pattern recognition receptors (PRRs) on immune cells detect pathogen-associated molecular patterns (PAMPs) present on parasites
    • Toll-like receptors (TLRs) recognize various PAMPs, including parasite surface molecules and DNA
    • C-type lectin receptors (CLRs) bind to carbohydrate structures on parasite surfaces
  • Antigen-presenting cells (APCs), such as dendritic cells and macrophages, process and present parasite antigens to T cells
    • Major histocompatibility complex (MHC) molecules on APCs display parasite peptides to T cells
    • MHC class I presents peptides to CD8+ T cells, while MHC class II presents peptides to CD4+ T cells
  • B cells recognize parasite antigens through their B cell receptors (BCRs) and can differentiate into antibody-secreting plasma cells
  • Antibodies can bind to parasite surface antigens, leading to neutralization, opsonization, or complement activation
  • Some parasites (Schistosoma) can induce the production of specific antibody isotypes (IgE) that contribute to protective immunity

Innate Immune Responses

  • Innate immune responses are the first line of defense against parasitic infections
  • Complement system activation leads to parasite lysis, opsonization, and recruitment of immune cells
    • Alternative pathway is activated by parasite surface molecules and amplifies the complement cascade
    • Lectin pathway is triggered by the binding of mannose-binding lectin (MBL) to parasite carbohydrates
  • Phagocytic cells (macrophages, neutrophils) engulf and destroy parasites through the production of reactive oxygen species (ROS) and nitric oxide (NO)
  • Natural killer (NK) cells recognize and kill parasite-infected cells through the release of cytotoxic granules containing perforin and granzymes
  • Innate lymphoid cells (ILCs) secrete cytokines that help shape the adaptive immune response and contribute to parasite clearance
  • Mast cells and eosinophils release granules containing toxic mediators that can damage parasites and promote inflammation
    • Eosinophils are particularly important in the defense against helminthic parasites

Adaptive Immune Responses

  • T cells play a central role in the adaptive immune response to parasitic infections
    • CD4+ T helper (Th) cells secrete cytokines that activate and coordinate other immune cells
      • Th1 cells produce IFN-γ, which activates macrophages and promotes cell-mediated immunity
      • Th2 cells secrete IL-4, IL-5, and IL-13, which stimulate B cell antibody production and eosinophil recruitment
    • CD8+ cytotoxic T lymphocytes (CTLs) directly kill parasite-infected cells through the release of cytotoxic granules
  • B cells differentiate into plasma cells that secrete parasite-specific antibodies
    • IgG antibodies opsonize parasites, enhancing phagocytosis and complement activation
    • IgE antibodies bind to Fc receptors on mast cells and eosinophils, triggering the release of toxic mediators
    • IgA antibodies in mucosal secretions can prevent parasite attachment and invasion
  • Memory T and B cells develop following initial exposure to parasites, providing long-lasting protection against reinfection
  • The balance between Th1 and Th2 responses is crucial in determining the outcome of parasitic infections
    • Some parasites (Leishmania) can subvert the immune response by promoting a Th2-biased environment

Evasion Strategies of Parasites

  • Parasites have evolved various mechanisms to evade or manipulate host immune responses
  • Antigenic variation allows parasites to alter their surface proteins, making it difficult for the immune system to recognize and eliminate them
    • Trypanosoma brucei, the causative agent of African sleeping sickness, undergoes rapid antigenic variation of its variant surface glycoprotein (VSG) coat
  • Some parasites (Plasmodium) can sequester themselves in specific tissues (brain, placenta) to avoid detection by the immune system
  • Parasites can modulate host immune responses by secreting immunomodulatory molecules
    • Schistosoma mansoni secretes a protein (Sm16) that inhibits the production of pro-inflammatory cytokines by macrophages
    • Toxoplasma gondii produces a kinase (ROP16) that suppresses IL-12 production, favoring a Th2-biased response
  • Parasites can exploit host immune regulatory mechanisms, such as the induction of regulatory T cells (Tregs) or the production of anti-inflammatory cytokines (IL-10, TGF-β)
  • Some parasites (Leishmania) can survive and replicate within host macrophages by inhibiting phagosome-lysosome fusion or by resisting the toxic effects of ROS and NO

Immunopathology in Parasitic Infections

  • While immune responses are essential for parasite control, they can also contribute to tissue damage and disease pathology
  • Excessive Th1 responses can lead to severe inflammation and organ damage
    • In Chagas disease, caused by Trypanosoma cruzi, chronic inflammation can result in cardiomyopathy and digestive tract disorders
    • In cerebral malaria, caused by Plasmodium falciparum, excessive inflammation can lead to brain swelling and neurological complications
  • Th2-mediated responses, particularly those involving IgE and eosinophils, can cause allergic-type reactions and tissue damage
    • In schistosomiasis, egg deposition in the liver can trigger granuloma formation and fibrosis, leading to portal hypertension
    • In lymphatic filariasis, caused by Wuchereria bancrofti and Brugia species, chronic inflammation can result in lymphedema and elephantiasis
  • Autoimmune reactions can occur when parasite antigens cross-react with host proteins (molecular mimicry)
    • In Chagas disease, T. cruzi antigens can induce autoantibodies that target heart muscle proteins, contributing to cardiac damage
  • Immunosuppression induced by parasites can increase susceptibility to secondary infections or reactivation of latent infections (e.g., tuberculosis, HIV)

Implications for Diagnosis and Treatment

  • Understanding the immune response to parasitic infections is crucial for developing effective diagnostic tools and treatments
  • Serological tests detect parasite-specific antibodies in the host's blood, indicating current or past infection
    • Enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody test (IFAT) are commonly used serological methods
    • Rapid diagnostic tests (RDTs) based on antigen detection are available for some parasitic diseases (malaria, leishmaniasis)
  • Molecular techniques, such as polymerase chain reaction (PCR), can detect parasite DNA in clinical samples, providing high sensitivity and specificity
  • Antiparasitic drugs target specific stages of the parasite life cycle or essential metabolic pathways
    • Artemisinin-based combination therapies (ACTs) are the first-line treatment for uncomplicated P. falciparum malaria
    • Praziquantel is the drug of choice for treating schistosomiasis by causing parasite tegument damage and paralysis
  • Vaccines aim to induce protective immune responses against parasites
    • The RTS,S/AS01 vaccine provides partial protection against P. falciparum malaria in young children
    • Vaccine development for other parasitic diseases (leishmaniasis, Chagas disease) is an active area of research
  • Immunotherapeutic approaches, such as the use of monoclonal antibodies or cytokine-based therapies, are being explored to modulate the immune response and improve parasite clearance
  • Combining antiparasitic drugs with immunomodulatory agents may enhance treatment efficacy and reduce the risk of drug resistance


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.